CGEM
Cullinan Therapeutics, Inc. · Healthcare
Director and 10% owner Ansbert Gadicke sold $1.6M of Cullinan Therapeutics, Inc.
Sold$1,616,749
$29.20Price
55,364Shares
−1%Stake
What CGEM did after the filing
- The stock from Thu, Sep 9 open, $28.96
- −19.1%
- S&P 500, same days
- +1.0%
Measured over 30 trading days, to the Oct 21 close.
Traded Fri, Sep 3. Filed Wed, Sep 8. Returns use the Sep 9 open and the Oct 21 close. Not investment advice.